191 related articles for article (PubMed ID: 23291295)
1. Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients.
Habbous S; Chu KP; Harland LT; La Delfa A; Fadhel E; Sun B; Xu W; Wong A; Howell D; Ringash J; Waldron J; O'Sullivan B; Goldstein D; Huang SH; Liu G
Oral Oncol; 2013 May; 49(5):407-12. PubMed ID: 23291295
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
3. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic impact of Charlson comorbidity index obtained from medical records and claims data on 1-year mortality and length of stay in gastric cancer patients].
Kyung MH; Yoon SJ; Ahn HS; Hwang SM; Seo HJ; Kim KH; Park HK
J Prev Med Public Health; 2009 Mar; 42(2):117-22. PubMed ID: 19349741
[TBL] [Abstract][Full Text] [Related]
6. Modified Charlson comorbidity index for predicting survival after liver transplantation.
Volk ML; Hernandez JC; Lok AS; Marrero JA
Liver Transpl; 2007 Nov; 13(11):1515-20. PubMed ID: 17969207
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
8. Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients.
Chokshi S; Ghobadi A; Athar M; Shah S; Dowell J
Anticancer Res; 2014 Oct; 34(10):5543-6. PubMed ID: 25275053
[TBL] [Abstract][Full Text] [Related]
9. The impact of comorbidity and age on survival with laryngeal cancer.
Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study.
Frenkel WJ; Jongerius EJ; Mandjes-van Uitert MJ; van Munster BC; de Rooij SE
J Am Geriatr Soc; 2014 Feb; 62(2):342-6. PubMed ID: 24521366
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
[TBL] [Abstract][Full Text] [Related]
14. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
[TBL] [Abstract][Full Text] [Related]
15. Impact of comorbidity on therapeutic decision-making in head and neck cancer: audit from a comprehensive cancer center in India.
Baijal G; Gupta T; Hotwani C; Laskar SG; Budrukkar A; Murthy V; Agarwal JP
Head Neck; 2012 Sep; 34(9):1251-4. PubMed ID: 22076917
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the Charlson comorbidity index on mortality following acute pulmonary embolism.
Ng AC; Chow V; Yong AS; Chung T; Kritharides L
Respiration; 2013; 85(5):408-16. PubMed ID: 23147354
[TBL] [Abstract][Full Text] [Related]
17. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
[TBL] [Abstract][Full Text] [Related]
18. [Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer?].
Lübke T; Mönig SP; Schneider PM; Hölscher AH; Bollschweiler E
Zentralbl Chir; 2003 Nov; 128(11):970-6. PubMed ID: 14669119
[TBL] [Abstract][Full Text] [Related]
19. Comorbidities in head and neck cancer: agreement between self-report and chart review.
Mukerji SS; Duffy SA; Fowler KE; Khan M; Ronis DL; Terrell JE
Otolaryngol Head Neck Surg; 2007 Apr; 136(4):536-42. PubMed ID: 17418247
[TBL] [Abstract][Full Text] [Related]
20. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients.
Fried L; Bernardini J; Piraino B
Am J Kidney Dis; 2001 Feb; 37(2):337-42. PubMed ID: 11157375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
